Lipid composition of lysosomal multilamellar bodies of male mouse urine.
about
Fabry disease: preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice.Migalastat HCl reduces globotriaosylsphingosine (lyso-Gb3) in Fabry transgenic mice and in the plasma of Fabry patients.Sex differences of urinary and kidney globotriaosylceramide and lyso-globotriaosylceramide in Fabry mice.
P2860
Lipid composition of lysosomal multilamellar bodies of male mouse urine.
description
1991 nî lūn-bûn
@nan
1991 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Lipid composition of lysosomal multilamellar bodies of male mouse urine.
@ast
Lipid composition of lysosomal multilamellar bodies of male mouse urine.
@en
Lipid composition of lysosomal multilamellar bodies of male mouse urine.
@nl
type
label
Lipid composition of lysosomal multilamellar bodies of male mouse urine.
@ast
Lipid composition of lysosomal multilamellar bodies of male mouse urine.
@en
Lipid composition of lysosomal multilamellar bodies of male mouse urine.
@nl
prefLabel
Lipid composition of lysosomal multilamellar bodies of male mouse urine.
@ast
Lipid composition of lysosomal multilamellar bodies of male mouse urine.
@en
Lipid composition of lysosomal multilamellar bodies of male mouse urine.
@nl
P2093
P1476
Lipid composition of lysosomal multilamellar bodies of male mouse urine.
@en
P2093
P304
P577
1991-01-01T00:00:00Z